Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X842 Phase 2 in Reflux Esophagitis
NCT04531475Phase 2Completed
- Sponsor
- Jiangsu Sinorda Biomedicine Co., Ltd.
- Start
- Jan 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linaprazan glurate in reflux esophagitis, sponsored by Jiangsu Sinorda Biomedicine Co., Ltd.. Started Jan 2020; status: completed.
02
Drugs
linaprazan glurate
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT04531475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04531475.